MicroRNA-19b-3p suppresses gastric cancer development by negatively regulating Neuropilin-1

Abstract

Background Gastric cancer (GC) remains one of the most common digestive malignancies worldwide and ranked third causes of cancer-related death. Mounting evidence has revealed that miRNAs exert critical regulatory roles in GC development. Methods Immunohistochemistry (IHC) and western blot assay were performed to determine the protein expression levels of neuropilin-1 (NRP1) and mRNA levels were confirmed by quantitative RT-PCR (qRT-PCR) in GC tissues. Kaplan–Meier analysis was performed to evaluate the prognostic value of NRP1 in GC. Knockdown of NRP1 was conducted to analyse its function in vitro and vivo. Luciferase reporter assay, western blot and qRT-qPCR were employed to identify the miRNAs which directly targeted NRP1. Furthermore, Bioinformatics analysis and experimental verification were used to explore the potential molecular mechanism and signaling pathway. Results In the current study, we revealed that neuropilin-1 (NRP1) was highly expressed in GC tumor tissues and was associated with poor prognosis in GC patients. NRP1 knockdown inhibited GC cell growth, migration and invasion in vitro, while suppressed GC xenograft tumor development in vivo. Bioinformatics analysis predicted that miR-19b-3p down-regulated NRP1 expression by targeting its 3’-UTR. Functional assay demonstrated that miR-19b-3p inhibited GC cell growth, migration and invasion via negatively regulating NRP1. Overexpression NRP1 partially reversed the regulatory effect of miR-19b-3p. Moreover, we showed that miR-19b-3p/NRP1 axis regulated the epithelial-to-mesenchymal transition and focal adhesion in GC, which might contribute the GC development and progression. Conclusions Taken together, our findings suggest a regulatory network of miR-19b-3p/NRP1 in GC development. The miR-19b-3p/NRP1 axis might be further explored as a potential diagnostic and therapeutic target in GC.

Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma

“…As reported in gastric cancer, miR-19b-3p was downregulated and negatively regulated neuropilin-1 [33]. In this study, through bioinformatics prediction and luciferase reporter and pull-down assay, RAB14 was found to be a potential target gene of miR-19b-3p.…”

The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

“…Thus, the ARGs signature-based prognostic nomogram was highly recommended for future clinical applications. Previous studies had demonstrated the influence of angiogenesis on tumor growth and progression (Katayama et al 2019;Carmeliet and Jain 2000;Ramjiawan et al 2017;Pavlakovic et al 2001;Schmidt and Carmeliet 2011;Baselga et al 2008;Goos et al 2016;Sbiera et al 2017;Wei et al 2020;Dunne et al 2006;Townsend et al 2019;Javaherian and Lee 2011;Lin et al 2003;Maurer et al 2006;Yang et al 2020). Moreover, inhibiting angiogenesis has emerged as an effective therapeutic strategy for most solid tumors.…”

MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway

“…5,6 This abnormal miRNA expression has been reported in a variety of cancers, 7,8 such as colorectal cancer, 9 oral cancer, 10 breast cancer, 11 and bladder cancer. 12 Unusual miR-19b expression has been reported in gastric cancer, 13 lung cancer, 14 and breast cancer. 15 In colon cancer, Zhang reported that miR-19b upregulation was associated with metastasis and poor prognosis.…”